Quote Mirikizumab
Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody targets the p19 subunit of interleukin 23. Mirikizumab can be used for the research of ulcerative colitis.
Read more
€0.00
(tax incl.)
Reference:
HY-P99737
Brand: